Phosphoinositide 3-kinase signalling - which way to target?

Author： Wymann M.P.   Zvelebil M.   Laffargue M.  

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.24, Iss.7, 2003-07, pp. : 366-376

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The phosphoinositide 3-kinase signalling pathway as a therapeutic target in squamous cell carcinoma of the head and neck

By Rogers Susanne J   Box Carol   Harrington Kevin J   Nutting Chris   Rhys-Evans Peter   Eccles Suzanne A  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 769-790

Informa Healthcare

Access to resources Recommend Favorite

The Phosphoinositide 3-Kinase Signaling Pathway as a Therapeutic Target in Grade IV Brain Tumors

By  

Current Cancer Drug Targets, Vol. 11, Iss. 8, 2011-10 ,pp. : 894-918

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic and Epigenetic Regulation of Phosphoinositide 3-kinase Isoforms

By  

Current Pharmaceutical Design, Vol. 19, Iss. 4, 2013-02 ,pp. : 680-686

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphoinositide 3-kinase α inhibitors: a patent review

By Denny William A  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 7, 2013-07 ,pp. : 789-799

Informa Healthcare

Access to resources Recommend Favorite

Phosphoinositide 3-kinase inhibition in cancer treatment

By Berrie Christopher P  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 6, 2001-06 ,pp. : 1085-1098

Informa Healthcare

Access to resources Recommend Favorite